|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
The lawsuit is filed in response to Par's pursuit of a generic version of heartburn drug Zegerid.
Acid reflux treatment Zegerid boosts second-quarter results, but the company pulls 2008 sales guidance.
Cramer believes Yahoo! should buy The Knot, but the wedding site's headed higher even if the two don't get hitched. Plus, Google $560 or bust.
DexCom shares jump after the FDA approves its glucose monitoring system.
As more people get diagnosed with diabetes, DexCom's new glucose monitoring device could be huge, says Cramer.
Idenix Pharmaceuticals jumps after reporting positive data for a hepatitis C treatment.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.